GeneReach Biotechnology Corp.

NT$15.00As of Sun 8 Nov 2026, 12:00 UTC
TPEx:4171Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 0.91%
Div yield —
ROE (7.60%)
Biotechnology
Beta (5Y) 0.40
PE TTM —
TSR TTM (39.39%)
Mkt cap NT$852.9M
ROIC (10.47%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$19
28.49%
30.62%
Hold 1|9|1|3|3
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.29
0.29
0.30
0.31
0.58%
2.55%
7.02%
1.67%
RevenueNT$M
62.70
61.30
64.42
64.75
(3.12%)
(3.17%)
4.15%
3.23%
Peers (US$25.76M)
Cap (US$)
PE
25.74M
—
Capital
TTM
5Y
10Y
Leveragex
1.929
(0.239)
(0.251)
EBIT/Intx
0.690
0.423
0.423
Own earn%
(829.75)
16.94
43.95
Sh yield%
12.59
29.16
28.53
Owners
Insiders/Inst%
4.28
89.88
Short interest%
2.55
SBC / revenue%
4.72
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
34–46
$1 testx
−0.1
Incr. ROIC%
4